Skip to content

Author

Filippo Angelini

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

[Ten questions about cardiogenetics].

In recent years, cardiogenetics has become a key component in the management of cardiomyopathies and channelopathies, reshaping diagnostic, prognostic, and therapeutic strategies for conditions characterized by substantial clinical heterogeneity and variable arrhythmic risk. However, the use of genetic testing in clini...

F. Fortuni, A. Matteucci, F. Angelini et al. · 0 citations
Open access Oct 2026

Beyond wall thickness: clinical predictors of genotype positivity in hypertrophic cardiomyopathy

Genetic testing in hypertrophic cardiomyopathy (HCM) yields variable positivity rates. Identifying clinical predictors of positive genetic tests could improve pre-test counseling and refine expectations about diagnostic yield. We analyzed consecutive genotyped HCM probands from a contemporary multicenter c...

F. Juvenal, F. Angelini, V. Dusi et al. · 0 citations
Sep 2026

Non-Invasive Hemodynamic And Echocardiographic Changes Following Vericiguat Initiation In Heart Failure With Reduced Ejection Fraction: A Prospective Registry Study.

Vericiguat reduces cardiovascular death and heart failure (HF) hospitalization in high-risk patients with HF and reduced ejection fraction (HFrEF), but its non-invasive haemodynamic and remodelling effects in real-world practice remain incompletely characterized. We aimed to evaluate changes in non-invasive hemodynamic...

P. Bocchino, C. Carbonaro, G. Gallone et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.